Genscript Biotech Stock Market Value
| GNNSF Stock | USD 1.90 0.04 2.15% |
| Symbol | Genscript |
Genscript Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genscript Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genscript Biotech.
| 01/31/2025 |
| 03/02/2025 |
If you would invest 0.00 in Genscript Biotech on January 31, 2025 and sell it all today you would earn a total of 0.00 from holding Genscript Biotech or generate 0.0% return on investment in Genscript Biotech over 30 days. Genscript Biotech is related to or competes with Telix Pharmaceuticals, Keros Therapeutics, Zentalis Pharmaceuticals, Innovent Biologics, Oxford Nanopore, Nuvalent, and Crinetics Pharmaceuticals. Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science resear... More
Genscript Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genscript Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genscript Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.21 | |||
| Information Ratio | 0.1168 | |||
| Maximum Drawdown | 33.97 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 13.39 |
Genscript Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genscript Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genscript Biotech's standard deviation. In reality, there are many statistical measures that can use Genscript Biotech historical prices to predict the future Genscript Biotech's volatility.| Risk Adjusted Performance | 0.093 | |||
| Jensen Alpha | 0.6172 | |||
| Total Risk Alpha | 0.8168 | |||
| Sortino Ratio | 0.0649 | |||
| Treynor Ratio | (0.66) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genscript Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Genscript Biotech Backtested Returns
Genscript Biotech appears to be dangerous, given 3 months investment horizon. Genscript Biotech holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14 % return per unit of risk over the last 3 months. By evaluating Genscript Biotech's technical indicators, you can evaluate if the expected return of 0.8% is justified by implied risk. Please utilize Genscript Biotech's Market Risk Adjusted Performance of (0.65), downside deviation of 10.21, and Risk Adjusted Performance of 0.093 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Genscript Biotech holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of -0.97, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Genscript Biotech are expected to decrease slowly. On the other hand, during market turmoil, Genscript Biotech is expected to outperform it slightly. Please check Genscript Biotech's sortino ratio, skewness, relative strength index, as well as the relationship between the potential upside and day median price , to make a quick decision on whether Genscript Biotech's current trending patterns will revert.
Auto-correlation | 0.09 |
Virtually no predictability
Genscript Biotech has virtually no predictability. Overlapping area represents the amount of predictability between Genscript Biotech time series from 31st of January 2025 to 15th of February 2025 and 15th of February 2025 to 2nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genscript Biotech price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Genscript Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Genscript Biotech lagged returns against current returns
Autocorrelation, which is Genscript Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genscript Biotech's pink sheet expected returns. We can calculate the autocorrelation of Genscript Biotech returns to help us make a trade decision. For example, suppose you find that Genscript Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Genscript Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genscript Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genscript Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genscript Biotech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Genscript Biotech Lagged Returns
When evaluating Genscript Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genscript Biotech pink sheet have on its future price. Genscript Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genscript Biotech autocorrelation shows the relationship between Genscript Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Genscript Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Genscript Pink Sheet
Genscript Biotech financial ratios help investors to determine whether Genscript Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genscript with respect to the benefits of owning Genscript Biotech security.